IPO backed by big pockets at 20c, maybe 15c with discount. A lot of progress made and new techs added but due to senseless general bio-tech sell off totally undervalued. 90+c is a 5 year outlook, not BS as one poster here wants to establish. In the US the MC would be about USD 1b based on recent deals made for pre-clinical drugs less advanced than CHM's.
GLTA
Ann: Response to ASX Query, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable